在结肠癌中,ANGEL2调节了野生型TP53翻译和多克索鲁比辛化学敏感性
Christopher August Lucchesi1, Saisamkalpa Mantrala2, Darren Tran2
1University of California, Davis, Sacramento, CA, United States.
Molecular cancer research : MCR
|March 7, 2025
概括
RNA结合蛋白 ANGEL2 通过与 EIF4E 相互作用来增强 TP53 翻译,防止抑制剂 RBM38 的结合. 失去ANGEL2会增加化学抵抗,但来自ANGEL2的可以恢复TP53水平和药物敏感性.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- RNA结合蛋白 ANGEL2 与癌症化学抵抗和患者生存有关.
- 通过 ANGEL2 影响癌症进展和化学抵抗的精确机制在很大程度上仍未确定.
研究的目的:
- 阐明 ANGEL2 调节癌症进展和化学抵抗的机制.
- 研究ANGEL2在调节瘤抑制蛋白TP53.3的翻译中的作用.
主要方法:
- 研究了ANGEL2和EIF4E (真核细胞翻译启动因子4E) 之间的相互作用.
- 评估了 ANGEL2 对 EIF4E 与 TP53 翻译抑制器 RBM38.3 的相互作用的影响.
- 利用癌细胞系来评估 ANGEL2 损失对细胞生长和化学抵抗的影响.
- 用一个来自ANGEL2的 (Pep7) 来评估其治疗潜力.
主要成果:
- 失去ANGEL2显著降低了瘤抑制蛋白TP53.3的表达.
- ANGEL2直接与EIF4E结合,抑制RBM38与EIF4E的相互作用,从而增强TP53的翻译.
- 癌细胞中ANGEL2的耗尽导致球状体生长的增加以及对多克索鲁比和埃托胺的抗性.
- 用Pep7治疗恢复了野生型TP53的表达,并使癌细胞对多克索鲁比敏感.
结论:
- ANGEL2通过调节EIF4E-RBM38复合体来促进野生型TP53转化,在癌症中起着至关重要的作用.
- 失去ANGEL2通过降低TP53转化,有助于化学抵抗.
- 由ANGEL2衍生而来的Pep7显示出治疗野生型TP53表达的癌症的治疗潜力.
更多相关视频
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K